Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - large image1
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - image1
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - image2
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - image3
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - image4
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - image5
high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2 buy - image6

high purity Semaglutide peptide weight management lyophilized powder CAS 2381089-83-2

7623 Inquiries

Unit Price:

$32-40/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShangHai

Brand:

YSXT

Packaging:

5mg 10mg 15mg 20mg 30mg/1vial,10vials/box

Sample Available:

Yes

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Description

    Salesperson:kiki

        whatsapp:+8618149392039

    Email: Kiki@xaysxt.com

     

    Product Introduction


    emaglutide is a lipopeptide with a linear sequence of 31 amino acids. Like human Glucagon-like peptide-1 (GLP-1), it is used in combination with diet and exercise in the therapy of type 2 diabetes mellitus. It works as an anti-obesity agent, a neuroprotective agent, and an appetite depressant.


    Product Description


    Items Specifications
    Product name semaglutide
    CAS No.CAS 910463-68-2
    Appearance
    White powder
    Function Weight loss
    Customized specifications 5mg 10mg 15mg 20mg 30mg /vial; 10vials/box
    Grade Pharmacy Grade

    Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 2 Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 3

    Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 4 Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 5 Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 6


     Company Overview   


    Established in 2022, we are guided by the business philosophy of integrity, cooperation, scientific innovation, and service priority. We are dedicated to becoming a globally leading supplier of high-quality peptides and pharmaceutical intermediates. Equipped with our own modern, independent manufacturing facility, our company is capable of large-scale production of pharmaceutical intermediates, organic intermediates, and various high-purity raw materials. These products are widely applied across diverse industries, including pharmaceutical research, health care products, cosmetics, nutritional supplements, and food additives. We firmly believe in surviving on quality and growing through reputation. From strict source control of raw materials to rigorous internal process management, we ensure that every product is safe, reliable, and of superior excellence.

    Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 7 Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 8

    Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 9 Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 10 Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 11

    Product Usage

    1. Powerful Glucose-Lowering (For Type 2 Diabetes)
    Tirzepatide is one of the most effective glucose-lowering drugs available. Its main mechanisms include:
    - Dual Incretin Effect: In a glucose-dependent manner, it stimulates pancreatic β-cells to secrete while inhibiting the secretion of glucagon , thereby achieving precise blood sugar regulation.
    - Improved Function: It enhances pancreatic β-cell function and sensitivity (IS), helping the body utilize glucose more effectively.
    - Delayed Absorption: By activating GLP-1 receptors, it delays gastric emptying and slows the absorption of sugars from food, thereby stabilizing postprandial blood glucose levels.
    - Efficacy Data: Clinical studies have shown that it is more effective in reducing glycated hemoglobin  than existing drugs such as dulaglutide and semaglutide. In some patients,  levels can return to normal after treatment.

    2. Significant Weight Loss (For Obesity/Overweight)
    This is another core effect of tirzepatide, with even greater weight loss efficacy than standalone GLP-1 drugs:
    - Appetite Suppression: It crosses the blood-brain barrier and acts on the appetite center in the hypothalamus. The GIP component not only enhances the weight loss effect of GLP-1 but also effectively suppresses appetite and increases satiety.
    - Metabolic Regulation: It acts on white adipose tissue, improving fat tissue function and reducing visceral fat accumulation.
    - Reduced Side Effects: Activation of GIP receptors also helps alleviate common gastrointestinal side effects associated with GLP-1 drugs, such as nausea and vomiting, improving tolerability.

    Shop high purity Tirzepatide peptide weight management lyophilized powder CAS 2023788-19-2-Detailed Image 12

    Shipping Mehtod

    Shop excellent peptide Semaglutide weight loss peptide lyophilized powder CAS 2381089-83-2-Detailed Image 12 Shop excellent peptide Semaglutide weight loss peptide lyophilized powder CAS 2381089-83-2-Detailed Image 13


      Q&A  



    Q: When can I receive the package?

    A: It will be shipped as soon as possible after payment, and the shipping time is generally 7 to 15 days.

    Q: What is the minimum amount I can order?

    A: The minimum quantity we can order is 1 box, which contains 10 vials.

    Q:How about the price? Can you make it cheaper?

    A:We always take the customer's benefit as the top priority. Price is negotiable under different conditions, we are assuring you to get the most competitive price. 

    Q: How do i keep the peptides when i receive it ?

    A: Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.


        Why Choose Us  


    Superiority

    1.High quality and competitive price.

    2.Promptly delivery by well-reputed shipping lines.

    3.We will inform you all the information at every stage in advance.

    4.Reply your inquiry in 24 working hours.

    5.Exclusive and unique solution can be provided to our customer by our well-trained and professional engineers and staff.

    6.As an honest seller, we always use superior raw material, advanced machines, skilled technicians to ensure our products  in high quality and stable feature


    Payment modes  


    Shop excellent peptide Semaglutide weight loss peptide lyophilized powder CAS 2381089-83-2-Detailed Image 14
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760 ; NCT05882045 ; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide

    Location:

    Room 1811-A096, Jingu Building, No. 319, Jinxing Middle Road, Xihu Street, Yuelu District, Changsha City, Hunan Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Employees:

    11-50

    Year of Establishment:

    2023

  • Inquiry History
    7623 Inquiries
    Country Product Purchase Quantity Date Posted
    Sweden

    Retatrutide RT30

    300 MG Nov 14, 2026
    Puerto Rico

    Retatrutide

    100 PCS Nov 14, 2026
    France

    Rétatrutide

    10 PCS Nov 14, 2026
    United States

    Retatrutide

    1 MT Nov 14, 2026
    Australia

    Retatrutide

    20 MG Nov 14, 2026
    United Kingdom

    Retatrutide

    1000 G Nov 14, 2026
    Australia

    retatrutide

    20 MG Nov 13, 2026
    United Kingdom

    retatrutide

    40 MG Nov 13, 2026
    United States

    retatrutide

    10 MG Nov 13, 2026
    United States

    retatrutide

    10 MG Nov 13, 2026
    United States

    Retatrutide

    50 MG Nov 13, 2026
    United Kingdom

    Retatrutide

    10 MG Nov 13, 2026
    United States

    Retatrutide

    600 MG Nov 13, 2026
    United States

    Retatrutide

    5 PCS Nov 12, 2026
    United States

    retatrutide

    20 MG Nov 12, 2026
    United States

    retatrutide

    10 MG Nov 12, 2026
    United States

    retatrutide

    10 MG Nov 12, 2026
    Mexico

    retatrutide

    10 MG Nov 12, 2026
    Germany

    retatrutide

    10 MG Nov 12, 2026
    Germany

    retatrutide

    1 G Nov 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.